Published in Medical Letter on the CDC and FDA, June 3rd, 2007
We welcome the introduction of the new and improved guidelines as part of the continuous evolution of clinical research. Whilst many, if not all of the proposed new guidelines should be good clinical research practice in quality clinical trial units, the introduction of these guidelines can only help to further enhance the UK's standing as leaders in the conduct of Phase I...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA